CBAY 32.48 (+0%)
US23257D1037BiotechnologyBiotechnology

CymaBay Therapeutics (CBAY) Financial Metrics

This table shows a selected set of financial data points of CymaBay Therapeutics (CBAY). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2022 -1.21 0 -5.19 550.53M -0.62 0 -84.23M -90.47M -106M 20.29M
2021 -1.3 0 -2.59 233.3M -0.51 0 -69.52M -86.75M -90M 125.81M
2020 -0.74 0 -7.76 395.45M -0.28 0 -44.75M -50.35M -50.99M 28.19M
2019 -1.53 0 -1.28 131.38M -0.52 0 -98.23M -97.73M -102.81M 24.87M
2018 -1.25 0 -6.27 455.19M -0.5 0 -55.47M -72.11M -72.55M 49M
2017 -0.79 0 -11.65 321.12M -0.45 10M -19.66M -26.44M -27.56M 23.05M
2016 -1.14 0 -1.52 40.56M -0.85 0 -23.4M -25.31M -26.67M 10.5M
2015 -0.82 0 -2.06 31.97M -0.39 0 -23.32M -14.59M -15.53M 7.71M
2014 -2.65 0 -3.71 118.44M -0.91 0 -21.22M -31.14M -31.92M 11.59M
2013 -0.72 0 0 0 -0.5 0 -8.46M -9.2M -10.07M 24.4M
2012 -0.8 0 0 0 0 3.05M -11.29M -10.3M -11.26M 7.73M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.